0      0


Regulatory Changes During a Pandemic (CMC /Inspections and Reviews)


May 18, 2021 10:03am ‐ May 18, 2021 11:05am


Credits: None available.

Description

Panel Discussion

Speaker(s):

  • David Churchward, Deputy Unit Manager, Inspectorate Strategy & Innovation, MHRA
  • Francis Godwin, Office Director, OMQ, OC, CDER, FDA
  • Paul A. Gustafson, Senior Corporate Regulatory Compliance and Enforcement Advisor, Regulatory Operations and Enforcement Branch (ROEB) Health Canada / Government of Canada
  • Valerie Jensen, CAPT (Ret.), RPh, Associate Director, Drug Shortage Staff, CDER/FDA
  • Elizabeth Miller, Pharm.D., Assistant Commissioner for Medical Products and Tobacco Operations, FDA/ORA
  • Kevin O'Donnell, PhD, Market Compliance Mgr & Sr Inspector, Health Products Regulatory Authority (HPRA)
  • Stelios C. Tsinontides, Ph.D., FAIChE, Director, Office of Pharmaceutical Manufacturing Assessment (OPMA), OPQ, CDER, FDA

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content